Pediatric Neurology News

Severe auditory dysfunction was a common neurobiological feature of neurofibromatosis type 1, according to results of a case-control study published in JAMA Network Open.

Study results published in JAMA Neurology show higher odds of seizures during rewarming correlate with death or disability at 2 years in infants at risk, demonstrating the need for EEG monitoring during rewarming.

Boys with autism spectrum disorder who received 10 mg/kg of a suramin IV infusion known as PAX-101 experienced greater improvements in symptoms than those who received 20 mg/kg of the same treatment or placebo, data show.

A virtual reality intervention called “Bear Blast” significantly decreased pain and anxiety among children and teenagers while they underwent peripheral IV catheter placement, trial data showed.

Amzell BV, a specialty pharmaceutical development company, announced it has a special protocol assessment agreement with the FDA for a phase 3 trial of its injectable infantile epileptic disease therapy.

Austedo did not efficaciously treat tics linked to Tourette syndrome in children and adolescents, according to results of a randomized clinical trial published in JAMA Network Open.

Young people with intracranial hypertension had an increased prevalence of disordered eating behaviors, according to study results published in Pediatric Neurology.

PTC Therapeutics Inc. released results of a 5-year analysis that showed its novel gene therapy, PTC-AADC, improved outcomes among children with aromatic L-amino acid decarboxylase deficiency.

A study published in The New England Journal of Medicine details how researchers discovered a previously unknown genetic disorder that affects prenatal development in children and identified a potential cure.